Skip to content

Optimized Management After Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension

Optimised Management After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04777448
Acronym
POpPART
Enrollment
54
Registered
2021-03-02
Start date
2021-04-30
Completion date
2023-07-31
Last updated
2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Thromboembolic Pulmonary Hypertension

Keywords

Chronic Thromboembolic Pulmonary Hypertension, Telerehabilitation

Brief summary

Balloon pulmonary angioplasty (BPA) is a new method of treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent CTEPH after surgery. BPA improves or even normalises hemodynamic parameters measured during a right heart catheterization. Nevertheless, the vast majority of patients retain dyspnea and impaired exercise capacity despite considerable hemodynamic improvements. Pulmonary rehabilitation (RHB) can improve symptoms, quality of life and exercise capacity in patients with CTEPH. Unfortunately, access to RHB remains a concern in many countries. Tele-rehabilitation (tRHB) has been shown feasible and effective some cardiac or pulmonary diseases. This randomized controlled study aims at comparing the effects of tRHB with the effects of simple advices regarding exercising in CTEPH patients with normalized or near-normalized pulmonary hemodynamics after BPA treatment.

Detailed description

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary embolism leading to dyspnea, effort limitation and sometimes right heart failure and death. Balloon pulmonary angioplasty (BPA) is a new method of treatment for inoperable CTEPH or persistent CTEPH after surgery. BPA restores blood flow in the treated areas and improves or even normalises hemodynamic parameters measured during a right heart catheterization. Nevertheless, the vast majority of patients retain dyspnea and impaired exercise capacity after angioplasty procedures. Exercise training has been demonstrated to alleviate exercise dyspnea and to improve exercise capacity in many chronic cardiopulmonary conditions. Pulmonary rehabilitation (RHB) can improve symptoms, quality of life and exercise capacity in patients with pulmonary vascular disease of different etiologies including CTEPH. Furthermore, RHB does not present any particular risk for CTEPH patients with normalized or near-normalized pulmonary hemodynamics. Unfortunately, access to RHB remains a concern in many countries. Tele-rehabilitation (tRHB) has been shown feasible and effective some cardiac or pulmonary diseases. Our hypothesis is that tRHB may also be effective in CTEPH patients with normalized or near-normalized pulmonary hemodynamics after BPA treatment. This randomized controlled study aims at comparing the effects of tRHB with the effects of simple advices regarding exercising in CTEPH patients with normalized or near-normalized pulmonary hemodynamics after BPA treatment.

Interventions

PROCEDUREtelerehabilitation

24 sessions (less Thant 1h hour each) of tele rehabilitation. Patients can choose among several activities (gym, dance, cardio training, ...)

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old * Patients who have undergone pulmonary angioplasty for CTEPH (group 4 of the international classification) * Patients with a mean pulmonary artery pressure \<= 30 mmHg and cardiac output \> 2.5 L/min/m2 at the last angioplasty session * Patients who had completed an incremental cardiopulmonary exercise test * Patients affiliated to the French social security system * Patients with signed informed consent

Exclusion criteria

* Patients unable to complete an incremental cardiopulmonary exercise test * Patients unable to complete a 6-minutes walking test, 3-minutes chair raising test and a rehabilitation * Patient unable, for technical or any other reason, to connect via the Internet for remote monitoring and/or telerehabilitation * Patient for whom a refusal to participate in a rehabilitation programme is anticipated * Patient who has participated in a rehabilitation programme in the 6 months prior to the date of inclusion * Patients referred to in Articles L1121-5 to L1121-8 of the CSP (pregnant women, parturients, nursing mothers, persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care and adults subject to a legal protection measure or unable to express their consent).

Design outcomes

Primary

MeasureTime frameDescription
Difference of endurance time on cycloergometerAt inclusion and after 3 monthsExpressed in seconds and calculated as follow: endurance time after 3 months - endurance time at inclusion The two tests are performed at 80% of the maximum power reached during a maximum incremental effort test (performed before inclusion)

Secondary

MeasureTime frameDescription
3-minutes chair rise test (3-CRT)At inclusion and at Month 3Number of rises during 3-CRT (n)
SF-36At inclusion and at Month 3Physical dimensions of the SF-36 questionnaire
Dyspnea (NYHA scale)At inclusion, at Month 1, Month 2 and Month 3Either I, II, III or IV
6-minutes walking test (6MWT)At inclusion and at Month 3Distance walked in 6-min (in meters)
St George Respiratory Questionnaire (SGRQ)At inclusion and at Month 3Total SGRQ score
Dyspnea (mMRC score)At inclusion, at Month 1, Month 2 and Month 3Either 0, 1, 2, 3 or 4
TelerehabilitationThrough study completion, an average of 3 monthsTotal number of sessions achieved

Contacts

Primary ContactBruno Degano, MD, PhD
BDegano@chu-grenoble.fr04 76 76 50 85

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026